1 results match your criteria: "and Clinical Professor with the University of British Columbia[Affiliation]"
Evaluation of Heparin Anticoagulation Protocols in Post-Renal Transplant Recipients (EHAP-PoRT Study).
Can J Hosp Pharm
May 2016
MD, FRCPC, is Renal Program Director with Providence Health Care, Medical Director of Kidney Transplantation with the BC Transplant Society, and Clinical Professor with the University of British Columbia, Vancouver, British Columbia.
Background: Disturbances in hemostasis are common among renal transplant recipients. Because of the risk of thromboembolism and graft loss after transplant, a prophylactic heparin protocol was implemented at St Paul's Hospital in Vancouver, British Columbia, in 2011. Therapeutic heparin is sometimes prescribed perioperatively for patients with preexisting prothrombotic conditions.
View Article and Find Full Text PDF